No. J2360 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code.

What NDCs are billed under J2360?

CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 3 NDCs under J2360, for Orphenadrine Citrate Injection. The table on this page shows each one with its billing units per package.

What is the Medicare payment limit for J2360?

$6.274 per 60 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

J2360 J-Code: Orphenadrine citrate — Billing Units & NDCs

In short

J2360 is the HCPCS Level II code for injection, orphenadrine citrate, up to 60 mg. CMS assigns NDCs for Orphenadrine Citrate Injection to it. The Medicare Part B payment limit is $6.274 per unit (October 1, 2026 through December 31, 2026).

Code

CMS HCPCS file

HCPCS codeJ2360

Billing unitSee descriptor

Descriptor: Injection, orphenadrine citrate, up to 60 mg
Short descriptor: Orphenadrine injection
Code set: HCPCS Level II, maintained by CMS
Effective: Jan 1, 1997

Medicare Part B payment limit

CMS ASP file

Payment limit per unit$6.274

Per60 mg

Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

HCPCS units

Modifier

NDC (11-digit)

NDC unit qualifier

NDC quantity

Enter the units to build the claim line.

NDCs billed under J2360

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 3 NDCs to J2360 for Orphenadrine Citrate Injection. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J2360 in the CMS ASP crosswalk
Drug	NDC (11-digit)	Labeler	Package	Billing units per package
Orphenadrine Citrate Injection	00641-6182-10	Hikma Pharmaceuticals USA Inc.	10 × 2	10
Orphenadrine Citrate Injection	00641-6182-25	Hikma Pharmaceuticals USA Inc.	25 × 2	25
Orphenadrine Citrate Injection	25021-0651-02	Sagent Pharmaceuticals	10 × 2	10

J2360: common questions

Is J2360 a CPT code?: No. J2360 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J2360?: CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 3 NDCs under J2360, for Orphenadrine Citrate Injection. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J2360?: $6.274 per 60 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

J2360 — Injection, orphenadrine citrate, up to 60 mg